172 related articles for article (PubMed ID: 16697896)
1. Peptide deformylase inhibitors.
Aubart K; Zalacain M
Prog Med Chem; 2006; 44():109-43. PubMed ID: 16697896
[No Abstract] [Full Text] [Related]
2. Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.
Boularot A; Giglione C; Artaud I; Meinnel T
Curr Opin Investig Drugs; 2004 Aug; 5(8):809-22. PubMed ID: 15600237
[TBL] [Abstract][Full Text] [Related]
3. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
[TBL] [Abstract][Full Text] [Related]
4. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
[TBL] [Abstract][Full Text] [Related]
5. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
[TBL] [Abstract][Full Text] [Related]
7. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.
Yuan Z; White RJ
Biochem Pharmacol; 2006 Mar; 71(7):1042-7. PubMed ID: 16289392
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
[TBL] [Abstract][Full Text] [Related]
9. Insight into the antibacterial drug design and architectural mechanism of peptide recognition from the E. faecium peptide deformylase structure.
Nam KH; Ham JI; Priyadarshi A; Kim EE; Chung N; Hwang KY
Proteins; 2009 Jan; 74(1):261-5. PubMed ID: 18831047
[No Abstract] [Full Text] [Related]
10. A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.
Howard MH; Cenizal T; Gutteridge S; Hanna WS; Tao Y; Totrov M; Wittenbach VA; Zheng YJ
J Med Chem; 2004 Dec; 47(27):6669-72. PubMed ID: 15615515
[TBL] [Abstract][Full Text] [Related]
11. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
Grant SK; Green BG; Kozarich JW
Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
[TBL] [Abstract][Full Text] [Related]
12. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M
In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
[TBL] [Abstract][Full Text] [Related]
14. Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Savinainen JR; Käsnänen H; Xhaard H; Nevalainen T; Laitinen JT; Poso A; Leppänen J; Saario SM
ChemMedChem; 2009 Aug; 4(8):1253-9. PubMed ID: 19472270
[No Abstract] [Full Text] [Related]
15. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
Calí P; Naerum L; Mukhija S; Hjelmencrantz A
Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
[TBL] [Abstract][Full Text] [Related]
16. Peptide deformylase as an antibacterial target: a critical assessment.
Leeds JA; Dean CR
Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the design of antibiotics targeting peptide deformylase.
Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
[TBL] [Abstract][Full Text] [Related]
18. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Seierstad M; Breitenbucher JG
J Med Chem; 2008 Dec; 51(23):7327-43. PubMed ID: 18983142
[No Abstract] [Full Text] [Related]
19. Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets.
Wang Q; Zhang D; Wang J; Cai Z; Xu W
Biophys Chem; 2006 Jun; 122(1):43-9. PubMed ID: 16545516
[TBL] [Abstract][Full Text] [Related]
20. Design of on-target FAAH inhibitors.
Deutsch DG
Chem Biol; 2005 Nov; 12(11):1157-8. PubMed ID: 16298293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
